U.S. flag

An official website of the United States government

NM_000219.6(KCNE1):c.253G>A (p.Asp85Asn) AND Long QT syndrome 5

Germline classification:
Likely benign; risk factor (2 submissions)
Last evaluated:
Jun 8, 2017
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000709727.14

Allele description [Variation Report for NM_000219.6(KCNE1):c.253G>A (p.Asp85Asn)]

NM_000219.6(KCNE1):c.253G>A (p.Asp85Asn)

Gene:
KCNE1:potassium voltage-gated channel subfamily E regulatory subunit 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
21q22.12
Genomic location:
Preferred name:
NM_000219.6(KCNE1):c.253G>A (p.Asp85Asn)
HGVS:
  • NC_000021.9:g.34449382C>T
  • NG_009091.1:g.66934G>A
  • NM_000219.6:c.253G>AMANE SELECT
  • NM_001127668.4:c.253G>A
  • NM_001127669.4:c.253G>A
  • NM_001127670.4:c.253G>A
  • NM_001270402.3:c.253G>A
  • NM_001270403.2:c.253G>A
  • NM_001270404.3:c.253G>A
  • NM_001270405.3:c.253G>A
  • NP_000210.2:p.Asp85Asn
  • NP_001121140.1:p.Asp85Asn
  • NP_001121141.1:p.Asp85Asn
  • NP_001121142.1:p.Asp85Asn
  • NP_001121142.1:p.Asp85Asn
  • NP_001257331.1:p.Asp85Asn
  • NP_001257332.1:p.Asp85Asn
  • NP_001257333.1:p.Asp85Asn
  • NP_001257334.1:p.Asp85Asn
  • NP_001257334.1:p.Asp85Asn
  • LRG_290t1:c.253G>A
  • LRG_290:g.66934G>A
  • NC_000021.8:g.35821680C>T
  • NM_000219.3:c.253G>A
  • NM_000219.4:c.253G>A
  • NM_000219.5:c.253G>A
  • NM_001127670.3:c.253G>A
  • NM_001270402.1:c.253G>A
  • NM_001270405.2:c.253G>A
  • P15382:p.Asp85Asn
  • c.253G>A
Protein change:
D85N; ASP85ASN
Links:
UniProtKB: P15382#VAR_008902; OMIM: 176261.0005; dbSNP: rs1805128
NCBI 1000 Genomes Browser:
rs1805128
Molecular consequence:
  • NM_000219.6:c.253G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127668.4:c.253G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127669.4:c.253G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127670.4:c.253G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001270402.3:c.253G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001270403.2:c.253G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001270404.3:c.253G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001270405.3:c.253G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Long QT syndrome 5 (LQT5)
Identifiers:
MONDO: MONDO:0013372; MedGen: C1867904; Orphanet: 101016; Orphanet: 768; OMIM: 613695

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000435787Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification Criteria 13 December 2019)
Likely benign
(Apr 27, 2017)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link,

SCV000839964Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine
criteria provided, single submitter

(ACMG Guidelines, 2015)
risk factor
(Jun 8, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients.

Paulussen AD, Gilissen RA, Armstrong M, Doevendans PA, Verhasselt P, Smeets HJ, Schulze-Bahr E, Haverkamp W, Breithardt G, Cohen N, Aerssens J.

J Mol Med (Berl). 2004 Mar;82(3):182-8. Epub 2004 Feb 4.

PubMed [citation]
PMID:
14760488

D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome.

Nishio Y, Makiyama T, Itoh H, Sakaguchi T, Ohno S, Gong YZ, Yamamoto S, Ozawa T, Ding WG, Toyoda F, Kawamura M, Akao M, Matsuura H, Kimura T, Kita T, Horie M.

J Am Coll Cardiol. 2009 Aug 25;54(9):812-9. doi: 10.1016/j.jacc.2009.06.005.

PubMed [citation]
PMID:
19695459
See all PubMed Citations (3)

Details of each submission

From Illumina Laboratory Services, Illumina, SCV000435787.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine, SCV000839964.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This c.253G>A (p.D85N) variant (rs1805128) in the KCNE1 gene is a potassium channel susceptibility allele for with diLQTS, defined as documented torsades de pointes during treatment with a QT-prolonging drug [PMID 22100668, 24400172, 22999324, 14760488, 21244686, 17161064]. The variant has also been associated with longer QT [PMID 16132053]. A previous study has shown to predict diLQTS with an odds ratio of 9.0 (95% confidence interval, 3.5–22.9) [PMID 22100668]. This variant is considered a risk allele for drug induced long QT.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 20, 2024